NO163819C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.

Info

Publication number
NO163819C
NO163819C NO844565A NO844565A NO163819C NO 163819 C NO163819 C NO 163819C NO 844565 A NO844565 A NO 844565A NO 844565 A NO844565 A NO 844565A NO 163819 C NO163819 C NO 163819C
Authority
NO
Norway
Prior art keywords
imidazo
carbon atoms
quinoline
derivatives
preparation
Prior art date
Application number
NO844565A
Other languages
English (en)
Norwegian (no)
Other versions
NO844565L (no
NO163819B (no
Inventor
John Franklin Gerster
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of NO844565L publication Critical patent/NO844565L/no
Priority to NO890824A priority Critical patent/NO165147C/no
Priority to NO890826A priority patent/NO168705C/no
Priority to NO890825A priority patent/NO169437C/no
Priority to NO890822A priority patent/NO165145C/no
Priority to NO890823A priority patent/NO165146C/no
Publication of NO163819B publication Critical patent/NO163819B/no
Publication of NO163819C publication Critical patent/NO163819C/no
Priority to NO1999015C priority patent/NO1999015I1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Physical Water Treatments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Alarm Systems (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Lubricants (AREA)
NO844565A 1983-11-18 1984-11-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav. NO163819C (no)

Priority Applications (6)

Application Number Priority Date Filing Date Title
NO890824A NO165147C (no) 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.
NO890826A NO168705C (no) 1983-11-18 1989-02-27 3-nitro-kinoliner.
NO890825A NO169437C (no) 1983-11-18 1989-02-27 3-amino-kinoliner.
NO890822A NO165145C (no) 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.
NO890823A NO165146C (no) 1983-11-18 1989-02-27 1h-imidazo-(4,5-c)-kinolin-4-klorforbindelser.
NO1999015C NO1999015I1 (no) 1983-11-18 1999-07-08 Imiquimod

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55315883A 1983-11-18 1983-11-18
US55315783A 1983-11-18 1983-11-18

Publications (3)

Publication Number Publication Date
NO844565L NO844565L (no) 1985-05-20
NO163819B NO163819B (no) 1990-04-17
NO163819C true NO163819C (no) 1990-08-01

Family

ID=27070262

Family Applications (7)

Application Number Title Priority Date Filing Date
NO844565A NO163819C (no) 1983-11-18 1984-11-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
NO890822A NO165145C (no) 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.
NO890824A NO165147C (no) 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.
NO890825A NO169437C (no) 1983-11-18 1989-02-27 3-amino-kinoliner.
NO890826A NO168705C (no) 1983-11-18 1989-02-27 3-nitro-kinoliner.
NO890823A NO165146C (no) 1983-11-18 1989-02-27 1h-imidazo-(4,5-c)-kinolin-4-klorforbindelser.
NO1999015C NO1999015I1 (no) 1983-11-18 1999-07-08 Imiquimod

Family Applications After (6)

Application Number Title Priority Date Filing Date
NO890822A NO165145C (no) 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.
NO890824A NO165147C (no) 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.
NO890825A NO169437C (no) 1983-11-18 1989-02-27 3-amino-kinoliner.
NO890826A NO168705C (no) 1983-11-18 1989-02-27 3-nitro-kinoliner.
NO890823A NO165146C (no) 1983-11-18 1989-02-27 1h-imidazo-(4,5-c)-kinolin-4-klorforbindelser.
NO1999015C NO1999015I1 (no) 1983-11-18 1999-07-08 Imiquimod

Country Status (15)

Country Link
EP (2) EP0145340B1 (sk)
JP (1) JPS60123488A (sk)
KR (1) KR900005657B1 (sk)
AT (2) ATE84525T1 (sk)
AU (2) AU581190B2 (sk)
CA (1) CA1271477A (sk)
DE (3) DE3486043T2 (sk)
DK (6) DK164280C (sk)
ES (1) ES8603477A1 (sk)
IE (1) IE57874B1 (sk)
IL (2) IL84537A (sk)
NL (2) NL980043I1 (sk)
NO (7) NO163819C (sk)
NZ (1) NZ210228A (sk)
PH (1) PH22338A (sk)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
CA1335996C (en) * 1988-02-16 1995-06-20 Susumu Takada 2-substituted carbonylimidazo¬4,5-c|quinolines
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
EP0385630B1 (en) * 1989-02-27 1996-11-27 Riker Laboratories, Inc. 1H-imidazo(4,5-c)Quinolin-4-amines as antivirals
CA2011504C (en) * 1989-03-07 1998-06-02 Kenji Ohmori Imidazoquinolone derivatives
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
CA2021338C (en) * 1989-07-18 1996-07-16 Fumio Suzuki Imidazoquinolone derivatives
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
FR2654021B1 (fr) * 1989-11-07 1992-02-28 Simond Jacques Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
GB8928281D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
ES2094772T3 (es) * 1990-06-01 1997-02-01 Kyowa Hakko Kogyo Kk Derivados de imidazonaftiridinas.
DE69229114T2 (de) * 1991-03-01 1999-11-04 Minnesota Mining And Mfg. Co., Saint Paul 1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5693811A (en) * 1996-06-21 1997-12-02 Minnesota Mining And Manufacturing Company Process for preparing tetrahdroimidazoquinolinamines
US6069149A (en) * 1997-01-09 2000-05-30 Terumo Kabushiki Kaisha Amide derivatives and intermediates for the synthesis thereof
JPH10298181A (ja) * 1997-04-25 1998-11-10 Sumitomo Pharmaceut Co Ltd タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤
JP2000119271A (ja) 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd １ｈ―イミダゾピリジン誘導体
WO2003035626A2 (en) * 2001-10-23 2003-05-01 Applied Research Systems Ars Holding N.V. Azole derivatives and pharmaceutical compositions containing them
GB0211649D0 (en) * 2002-05-21 2002-07-03 Novartis Ag Organic compounds
WO2004009593A1 (en) 2002-07-23 2004-01-29 Biogal Gyogyszergyar Rt. Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via1h-imidazo [4,5-c]quinolin-4-phthalimide intermediates
SI1539752T1 (sl) 2002-07-26 2007-08-31 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Priprava 1H-imidazo(4,5-c)kinolin-4-aminov preko novih imidazo(4,5-c)kinolin-4-ciano in 1H-imidazo(4,5-c)kinolin-4- karboksamidnih intermediatov
WO2005018556A2 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
ES2406730T3 (es) 2003-08-27 2013-06-07 3M Innovative Properties Company Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
CA2536530A1 (en) 2003-10-01 2005-04-14 Taro Pharmaceuticals U.S.A., Inc. Method of preparing 4-amino-1h-imidazo(4,5-c)quinolines and acid addition salts thereof
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
ITMI20032121A1 (it) * 2003-11-04 2005-05-05 Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm Procedimento per la preparazione di imiquimod e suoi intermedi
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
WO2005048945A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
CA2559863A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
EP1869043A2 (en) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
JP2009504803A (ja) 2005-08-22 2009-02-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｔｌｒアゴニスト
US8846697B2 (en) 2006-05-31 2014-09-30 The Regents Of The University Of California Purine analogs
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
EA019151B1 (ru) 2007-02-07 2014-01-30 Дзе Регентс Оф Дзе Юниверсити Оф Калифорния Конъюгаты синтетических агонистов tlr и их применение
EP2009002A1 (en) * 2007-06-21 2008-12-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
SG173617A1 (en) 2009-02-11 2011-09-29 Univ California Toll-like receptor modulators and treatment of diseases
HUE033901T2 (en) * 2010-08-17 2018-01-29 3M Innovative Properties Co Formulations and formulations for lipidized immune response modifying compounds and related processes
US8728486B2 (en) 2011-05-18 2014-05-20 University Of Kansas Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
EP2763677B1 (en) * 2011-10-04 2020-02-26 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
CN104968200B (zh) * 2013-02-01 2018-03-06 维尔斯达医疗公司 具有抗炎、抗真菌、抗寄生物和抗癌活性的胺化合物
BR112015022923A2 (pt) 2013-03-15 2017-07-18 Syngenta Participations Ag derivados de imidazopiridina microbicidamente ativos
ES2538880B1 (es) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
CN105899539B (zh) 2014-01-10 2021-11-09 博笛生物科技有限公司 用于免疫疗法的化合物和组合物
EP4001311A1 (en) 2014-07-09 2022-05-25 Birdie Biopharmaceuticals Inc. Anti-pd-l1 combinations for treating tumors
CN108137586B (zh) * 2015-09-14 2021-04-13 辉瑞大药厂 作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物
CN106943596A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于治疗肿瘤的抗-cd20组合
CN106943597A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于治疗肿瘤的抗-egfr组合
US10533007B2 (en) 2016-04-19 2020-01-14 Innate Tumor Immunity, Inc. NLRP3 modulators
MX2018012249A (es) 2016-04-19 2019-02-07 Innate Tumor Immunity Inc Moduladores de nlpr3.
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI674261B (zh) 2017-02-17 2019-10-11 美商英能腫瘤免疫股份有限公司 Nlrp3 調節劑
CN118515666A (zh) 2017-04-27 2024-08-20 博笛生物科技有限公司 2-氨基-喹啉衍生物
JP7080501B2 (ja) 2017-06-23 2022-06-06 バーディー バイオファーマシューティカルズ インコーポレイテッド 医薬品組成物
FR3113287B1 (fr) 2020-08-07 2023-06-23 Phv Pharma Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700674A (en) * 1969-04-30 1972-10-24 American Cyanamid Co 4-alkylamino-3-nitroquinolines
ZA832938B (en) * 1982-05-03 1984-12-24 Lilly Co Eli 2-phenylimidazo(4,5-c)pyridines

Also Published As

Publication number Publication date
DK135891A (da) 1991-07-16
JPS60123488A (ja) 1985-07-02
NO890822D0 (no) 1989-02-27
KR900005657B1 (ko) 1990-08-03
NO890825D0 (no) 1989-02-27
DK165921C (da) 1993-06-28
DK135891D0 (da) 1991-07-16
DE3486043D1 (de) 1993-02-25
DK164451C (da) 1992-11-09
DK164280C (da) 1992-11-30
DK164452C (da) 1992-11-09
DK164455C (da) 1992-11-16
DE19975027I2 (de) 2000-09-21
DK135991D0 (da) 1991-07-16
DK169179B1 (da) 1994-09-05
NO890823L (no) 1985-05-20
NO165146C (no) 1991-01-02
ATE84525T1 (de) 1993-01-15
DK136091A (da) 1991-07-16
DK135791D0 (da) 1991-07-16
ES537677A0 (es) 1985-12-16
NL980043I1 (nl) 1999-02-01
NO890824D0 (no) 1989-02-27
NO165146B (no) 1990-09-24
NO890826D0 (no) 1989-02-27
DK135991A (da) 1991-07-16
KR850003890A (ko) 1985-06-29
NO165145B (no) 1990-09-24
DK164451B (da) 1992-06-29
NO890824L (no) 1985-05-20
NO890825L (no) 1985-05-20
EP0145340A3 (en) 1986-06-11
DK164280B (da) 1992-06-01
DK542684D0 (da) 1984-11-15
IL84537A (en) 1990-12-23
IE57874B1 (en) 1993-05-05
CA1271477A (en) 1990-07-10
NO168705B (no) 1991-12-16
DK542684A (da) 1985-05-19
NO169437B (no) 1992-03-16
JPH0586391B2 (sk) 1993-12-10
AU611997B2 (en) 1991-06-27
IE842952L (en) 1985-05-18
NO169437C (no) 1992-06-24
ATE49763T1 (de) 1990-02-15
DE3486043T2 (de) 1993-06-03
NL980041I1 (nl) 1999-02-01
AU2991189A (en) 1989-06-15
ES8603477A1 (es) 1985-12-16
DK165921B (da) 1993-02-08
NO1999015I1 (no) 1999-07-08
NO844565L (no) 1985-05-20
NO890823D0 (no) 1989-02-27
NO168705C (no) 1992-03-25
DK164455B (da) 1992-06-29
NO165147C (no) 1991-01-02
DK136091D0 (da) 1991-07-16
DK164452B (da) 1992-06-29
EP0310950B1 (en) 1993-01-13
NO890822L (no) 1985-05-20
DK135791A (da) 1991-07-16
DK136191D0 (da) 1991-07-16
DK136191A (da) 1991-07-16
PH22338A (en) 1988-08-12
IL84537A0 (en) 1988-04-29
DE3481124D1 (de) 1990-03-01
NO890826L (no) 1985-05-20
EP0145340A2 (en) 1985-06-19
NL980041I2 (nl) 1999-07-01
NO163819B (no) 1990-04-17
NO165145C (no) 1991-01-02
EP0145340B1 (en) 1990-01-24
EP0310950A1 (en) 1989-04-12
AU3540284A (en) 1985-05-23
AU581190B2 (en) 1989-02-16
NZ210228A (en) 1989-01-27
NO165147B (no) 1990-09-24

Similar Documents

Publication Publication Date Title
NO163819C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees